Compile Data Set for Download or QSAR
maximum 50k data
Found 256 Enz. Inhib. hit(s) with all data for entry = 10164
TargetProtein arginine N-methyltransferase 5(Homo sapiens (Human))
Sk Biopharmaceuticals

US Patent
LigandPNGBDBM518031(4-[(2R)-3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydr...)
Affinity DataIC50:  50nMAssay Description:Experimental procedure: The histone H4 peptide was diluted with carbonate-bicarbonate buffer and prepared to 100 μg/mL, and then dispensed onto ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein arginine N-methyltransferase 5(Homo sapiens (Human))
Sk Biopharmaceuticals

US Patent
LigandPNGBDBM518033(8-[(8-acetyl-8-azabicyclo[3.2.1]octan-3-yl)oxy]-4-...)
Affinity DataIC50:  50nMAssay Description:Experimental procedure: The histone H4 peptide was diluted with carbonate-bicarbonate buffer and prepared to 100 μg/mL, and then dispensed onto ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein arginine N-methyltransferase 5(Homo sapiens (Human))
Sk Biopharmaceuticals

US Patent
LigandPNGBDBM518034(8-[(2-acetyl-2-azaspiro[3.3]heptan-6-yl)oxy]-4-[(2...)
Affinity DataIC50:  50nMAssay Description:Experimental procedure: The histone H4 peptide was diluted with carbonate-bicarbonate buffer and prepared to 100 μg/mL, and then dispensed onto ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein arginine N-methyltransferase 5(Homo sapiens (Human))
Sk Biopharmaceuticals

US Patent
LigandPNGBDBM518040(8-[(1-acetyl-4-piperidyl)oxy]-4-[(2R)-3-(3,4-dihyd...)
Affinity DataIC50:  50nMAssay Description:Experimental procedure: The histone H4 peptide was diluted with carbonate-bicarbonate buffer and prepared to 100 μg/mL, and then dispensed onto ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein arginine N-methyltransferase 5(Homo sapiens (Human))
Sk Biopharmaceuticals

US Patent
LigandPNGBDBM518060(4-[(2R)-3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydr...)
Affinity DataIC50:  50nMAssay Description:Experimental procedure: The histone H4 peptide was diluted with carbonate-bicarbonate buffer and prepared to 100 μg/mL, and then dispensed onto ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein arginine N-methyltransferase 5(Homo sapiens (Human))
Sk Biopharmaceuticals

US Patent
LigandPNGBDBM518061(4-[(2R)-3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydr...)
Affinity DataIC50:  50nMAssay Description:Experimental procedure: The histone H4 peptide was diluted with carbonate-bicarbonate buffer and prepared to 100 μg/mL, and then dispensed onto ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein arginine N-methyltransferase 5(Homo sapiens (Human))
Sk Biopharmaceuticals

US Patent
LigandPNGBDBM518063((2S)-4-[(2R)-3-(3,4-dihydro-1H-isoquinolin-2-yl)-2...)
Affinity DataIC50:  50nMAssay Description:Experimental procedure: The histone H4 peptide was diluted with carbonate-bicarbonate buffer and prepared to 100 μg/mL, and then dispensed onto ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein arginine N-methyltransferase 5(Homo sapiens (Human))
Sk Biopharmaceuticals

US Patent
LigandPNGBDBM518079(8-(cyclopropanecarbonyl)-4-[(2R)-3-(3,4-dihydro-1H...)
Affinity DataIC50:  50nMAssay Description:Experimental procedure: The histone H4 peptide was diluted with carbonate-bicarbonate buffer and prepared to 100 μg/mL, and then dispensed onto ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein arginine N-methyltransferase 5(Homo sapiens (Human))
Sk Biopharmaceuticals

US Patent
LigandPNGBDBM518082((2R)-4-[(2R)-3-(3,4-dihydro-1H-isoquinolin-2-yl)-2...)
Affinity DataIC50:  50nMAssay Description:Experimental procedure: The histone H4 peptide was diluted with carbonate-bicarbonate buffer and prepared to 100 μg/mL, and then dispensed onto ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein arginine N-methyltransferase 5(Homo sapiens (Human))
Sk Biopharmaceuticals

US Patent
LigandPNGBDBM518089(4-[(2R)-3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydr...)
Affinity DataIC50:  50nMAssay Description:Experimental procedure: The histone H4 peptide was diluted with carbonate-bicarbonate buffer and prepared to 100 μg/mL, and then dispensed onto ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein arginine N-methyltransferase 5(Homo sapiens (Human))
Sk Biopharmaceuticals

US Patent
LigandPNGBDBM518090(4-[(2R)-3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydr...)
Affinity DataIC50:  50nMAssay Description:Experimental procedure: The histone H4 peptide was diluted with carbonate-bicarbonate buffer and prepared to 100 μg/mL, and then dispensed onto ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein arginine N-methyltransferase 5(Homo sapiens (Human))
Sk Biopharmaceuticals

US Patent
LigandPNGBDBM518091(4-[(2R)-3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydr...)
Affinity DataIC50:  50nMAssay Description:Experimental procedure: The histone H4 peptide was diluted with carbonate-bicarbonate buffer and prepared to 100 μg/mL, and then dispensed onto ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein arginine N-methyltransferase 5(Homo sapiens (Human))
Sk Biopharmaceuticals

US Patent
LigandPNGBDBM518093(4-[(2R)-3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydr...)
Affinity DataIC50:  50nMAssay Description:Experimental procedure: The histone H4 peptide was diluted with carbonate-bicarbonate buffer and prepared to 100 μg/mL, and then dispensed onto ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein arginine N-methyltransferase 5(Homo sapiens (Human))
Sk Biopharmaceuticals

US Patent
LigandPNGBDBM518094(4-[(2R)-3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydr...)
Affinity DataIC50:  50nMAssay Description:Experimental procedure: The histone H4 peptide was diluted with carbonate-bicarbonate buffer and prepared to 100 μg/mL, and then dispensed onto ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein arginine N-methyltransferase 5(Homo sapiens (Human))
Sk Biopharmaceuticals

US Patent
LigandPNGBDBM518097(4-[(2R)-3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydr...)
Affinity DataIC50:  50nMAssay Description:Experimental procedure: The histone H4 peptide was diluted with carbonate-bicarbonate buffer and prepared to 100 μg/mL, and then dispensed onto ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein arginine N-methyltransferase 5(Homo sapiens (Human))
Sk Biopharmaceuticals

US Patent
LigandPNGBDBM518101((2R)-4-[(2R)-3-(3,4-dihydro-1H-isoquinolin-2-yl)-2...)
Affinity DataIC50:  50nMAssay Description:Experimental procedure: The histone H4 peptide was diluted with carbonate-bicarbonate buffer and prepared to 100 μg/mL, and then dispensed onto ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein arginine N-methyltransferase 5(Homo sapiens (Human))
Sk Biopharmaceuticals

US Patent
LigandPNGBDBM518102(4-[(2R)-3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydr...)
Affinity DataIC50:  50nMAssay Description:Experimental procedure: The histone H4 peptide was diluted with carbonate-bicarbonate buffer and prepared to 100 μg/mL, and then dispensed onto ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein arginine N-methyltransferase 5(Homo sapiens (Human))
Sk Biopharmaceuticals

US Patent
LigandPNGBDBM518106(4-[(2R)-3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydr...)
Affinity DataIC50:  50nMAssay Description:Experimental procedure: The histone H4 peptide was diluted with carbonate-bicarbonate buffer and prepared to 100 μg/mL, and then dispensed onto ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein arginine N-methyltransferase 5(Homo sapiens (Human))
Sk Biopharmaceuticals

US Patent
LigandPNGBDBM517863(2-[(2R)-3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydr...)
Affinity DataIC50:  50nMAssay Description:Experimental procedure: The histone H4 peptide was diluted with carbonate-bicarbonate buffer and prepared to 100 μg/mL, and then dispensed onto ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein arginine N-methyltransferase 5(Homo sapiens (Human))
Sk Biopharmaceuticals

US Patent
LigandPNGBDBM517869(4-[(2R)-3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydr...)
Affinity DataIC50:  50nMAssay Description:Experimental procedure: The histone H4 peptide was diluted with carbonate-bicarbonate buffer and prepared to 100 μg/mL, and then dispensed onto ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein arginine N-methyltransferase 5(Homo sapiens (Human))
Sk Biopharmaceuticals

US Patent
LigandPNGBDBM517870(4-[(2R)-3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydr...)
Affinity DataIC50:  50nMAssay Description:Experimental procedure: The histone H4 peptide was diluted with carbonate-bicarbonate buffer and prepared to 100 μg/mL, and then dispensed onto ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein arginine N-methyltransferase 5(Homo sapiens (Human))
Sk Biopharmaceuticals

US Patent
LigandPNGBDBM517874(4-[(2R)-3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydr...)
Affinity DataIC50:  50nMAssay Description:Experimental procedure: The histone H4 peptide was diluted with carbonate-bicarbonate buffer and prepared to 100 μg/mL, and then dispensed onto ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein arginine N-methyltransferase 5(Homo sapiens (Human))
Sk Biopharmaceuticals

US Patent
LigandPNGBDBM517875(8-(1-acetyl-3,6-dihydro-2H-pyridin-4-yl)-4-[(2R)-3...)
Affinity DataIC50:  50nMAssay Description:Experimental procedure: The histone H4 peptide was diluted with carbonate-bicarbonate buffer and prepared to 100 μg/mL, and then dispensed onto ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein arginine N-methyltransferase 5(Homo sapiens (Human))
Sk Biopharmaceuticals

US Patent
LigandPNGBDBM517871(US11111237, Example 14 | US11111237, Example 17 | ...)
Affinity DataIC50:  50nMAssay Description:Experimental procedure: The histone H4 peptide was diluted with carbonate-bicarbonate buffer and prepared to 100 μg/mL, and then dispensed onto ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein arginine N-methyltransferase 5(Homo sapiens (Human))
Sk Biopharmaceuticals

US Patent
LigandPNGBDBM517881(4-[(2R)-3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydr...)
Affinity DataIC50:  50nMAssay Description:Experimental procedure: The histone H4 peptide was diluted with carbonate-bicarbonate buffer and prepared to 100 μg/mL, and then dispensed onto ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein arginine N-methyltransferase 5(Homo sapiens (Human))
Sk Biopharmaceuticals

US Patent
LigandPNGBDBM517882(4-[(2R)-3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydr...)
Affinity DataIC50:  50nMAssay Description:Experimental procedure: The histone H4 peptide was diluted with carbonate-bicarbonate buffer and prepared to 100 μg/mL, and then dispensed onto ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein arginine N-methyltransferase 5(Homo sapiens (Human))
Sk Biopharmaceuticals

US Patent
LigandPNGBDBM517883(4-[(2R)-3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydr...)
Affinity DataIC50:  50nMAssay Description:Experimental procedure: The histone H4 peptide was diluted with carbonate-bicarbonate buffer and prepared to 100 μg/mL, and then dispensed onto ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein arginine N-methyltransferase 5(Homo sapiens (Human))
Sk Biopharmaceuticals

US Patent
LigandPNGBDBM517886(4-[(2R)-3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydr...)
Affinity DataIC50:  50nMAssay Description:Experimental procedure: The histone H4 peptide was diluted with carbonate-bicarbonate buffer and prepared to 100 μg/mL, and then dispensed onto ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein arginine N-methyltransferase 5(Homo sapiens (Human))
Sk Biopharmaceuticals

US Patent
LigandPNGBDBM517887(4-[(2R)-3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydr...)
Affinity DataIC50:  50nMAssay Description:Experimental procedure: The histone H4 peptide was diluted with carbonate-bicarbonate buffer and prepared to 100 μg/mL, and then dispensed onto ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein arginine N-methyltransferase 5(Homo sapiens (Human))
Sk Biopharmaceuticals

US Patent
LigandPNGBDBM517889(4-[(2R)-3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydr...)
Affinity DataIC50:  50nMAssay Description:Experimental procedure: The histone H4 peptide was diluted with carbonate-bicarbonate buffer and prepared to 100 μg/mL, and then dispensed onto ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein arginine N-methyltransferase 5(Homo sapiens (Human))
Sk Biopharmaceuticals

US Patent
LigandPNGBDBM517890(8-[(4,4-difluoro-1-piperidyl)methyl]-4-[(2R)-3-(3,...)
Affinity DataIC50:  50nMAssay Description:Experimental procedure: The histone H4 peptide was diluted with carbonate-bicarbonate buffer and prepared to 100 μg/mL, and then dispensed onto ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein arginine N-methyltransferase 5(Homo sapiens (Human))
Sk Biopharmaceuticals

US Patent
LigandPNGBDBM517891(4-[(2R)-3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydr...)
Affinity DataIC50:  50nMAssay Description:Experimental procedure: The histone H4 peptide was diluted with carbonate-bicarbonate buffer and prepared to 100 μg/mL, and then dispensed onto ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein arginine N-methyltransferase 5(Homo sapiens (Human))
Sk Biopharmaceuticals

US Patent
LigandPNGBDBM517893(8-(3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrol-...)
Affinity DataIC50:  50nMAssay Description:Experimental procedure: The histone H4 peptide was diluted with carbonate-bicarbonate buffer and prepared to 100 μg/mL, and then dispensed onto ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein arginine N-methyltransferase 5(Homo sapiens (Human))
Sk Biopharmaceuticals

US Patent
LigandPNGBDBM517899(4-[(2R)-3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydr...)
Affinity DataIC50:  50nMAssay Description:Experimental procedure: The histone H4 peptide was diluted with carbonate-bicarbonate buffer and prepared to 100 μg/mL, and then dispensed onto ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein arginine N-methyltransferase 5(Homo sapiens (Human))
Sk Biopharmaceuticals

US Patent
LigandPNGBDBM517902(4-[(2R)-3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydr...)
Affinity DataIC50:  50nMAssay Description:Experimental procedure: The histone H4 peptide was diluted with carbonate-bicarbonate buffer and prepared to 100 μg/mL, and then dispensed onto ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein arginine N-methyltransferase 5(Homo sapiens (Human))
Sk Biopharmaceuticals

US Patent
LigandPNGBDBM517903(4-[(2R)-3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydr...)
Affinity DataIC50:  50nMAssay Description:Experimental procedure: The histone H4 peptide was diluted with carbonate-bicarbonate buffer and prepared to 100 μg/mL, and then dispensed onto ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein arginine N-methyltransferase 5(Homo sapiens (Human))
Sk Biopharmaceuticals

US Patent
LigandPNGBDBM517904(4-[(2R)-3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydr...)
Affinity DataIC50:  50nMAssay Description:Experimental procedure: The histone H4 peptide was diluted with carbonate-bicarbonate buffer and prepared to 100 μg/mL, and then dispensed onto ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein arginine N-methyltransferase 5(Homo sapiens (Human))
Sk Biopharmaceuticals

US Patent
LigandPNGBDBM517909(4-[(2R)-3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydr...)
Affinity DataIC50:  50nMAssay Description:Experimental procedure: The histone H4 peptide was diluted with carbonate-bicarbonate buffer and prepared to 100 μg/mL, and then dispensed onto ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein arginine N-methyltransferase 5(Homo sapiens (Human))
Sk Biopharmaceuticals

US Patent
LigandPNGBDBM517913(4-[(2R)-3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydr...)
Affinity DataIC50:  50nMAssay Description:Experimental procedure: The histone H4 peptide was diluted with carbonate-bicarbonate buffer and prepared to 100 μg/mL, and then dispensed onto ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein arginine N-methyltransferase 5(Homo sapiens (Human))
Sk Biopharmaceuticals

US Patent
LigandPNGBDBM517916(4-[(2R)-3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydr...)
Affinity DataIC50:  50nMAssay Description:Experimental procedure: The histone H4 peptide was diluted with carbonate-bicarbonate buffer and prepared to 100 μg/mL, and then dispensed onto ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein arginine N-methyltransferase 5(Homo sapiens (Human))
Sk Biopharmaceuticals

US Patent
LigandPNGBDBM517917(4-[(2R)-3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydr...)
Affinity DataIC50:  50nMAssay Description:Experimental procedure: The histone H4 peptide was diluted with carbonate-bicarbonate buffer and prepared to 100 μg/mL, and then dispensed onto ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein arginine N-methyltransferase 5(Homo sapiens (Human))
Sk Biopharmaceuticals

US Patent
LigandPNGBDBM517921(4-[(2R)-3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydr...)
Affinity DataIC50:  50nMAssay Description:Experimental procedure: The histone H4 peptide was diluted with carbonate-bicarbonate buffer and prepared to 100 μg/mL, and then dispensed onto ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein arginine N-methyltransferase 5(Homo sapiens (Human))
Sk Biopharmaceuticals

US Patent
LigandPNGBDBM517922(4-[(2R)-3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydr...)
Affinity DataIC50:  50nMAssay Description:Experimental procedure: The histone H4 peptide was diluted with carbonate-bicarbonate buffer and prepared to 100 μg/mL, and then dispensed onto ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein arginine N-methyltransferase 5(Homo sapiens (Human))
Sk Biopharmaceuticals

US Patent
LigandPNGBDBM517923(4-[(2R)-3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydr...)
Affinity DataIC50:  50nMAssay Description:Experimental procedure: The histone H4 peptide was diluted with carbonate-bicarbonate buffer and prepared to 100 μg/mL, and then dispensed onto ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein arginine N-methyltransferase 5(Homo sapiens (Human))
Sk Biopharmaceuticals

US Patent
LigandPNGBDBM517928(4-[(2R)-3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydr...)
Affinity DataIC50:  50nMAssay Description:Experimental procedure: The histone H4 peptide was diluted with carbonate-bicarbonate buffer and prepared to 100 μg/mL, and then dispensed onto ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein arginine N-methyltransferase 5(Homo sapiens (Human))
Sk Biopharmaceuticals

US Patent
LigandPNGBDBM517936(US11111237, Example 77 | US11725001, Example 77 | ...)
Affinity DataIC50:  50nMAssay Description:Experimental procedure: The histone H4 peptide was diluted with carbonate-bicarbonate buffer and prepared to 100 μg/mL, and then dispensed onto ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein arginine N-methyltransferase 5(Homo sapiens (Human))
Sk Biopharmaceuticals

US Patent
LigandPNGBDBM517937(8-[(1-acetyl-4-piperidyl)oxy]-4-[(2R)-3-(3,4-dihyd...)
Affinity DataIC50:  50nMAssay Description:Experimental procedure: The histone H4 peptide was diluted with carbonate-bicarbonate buffer and prepared to 100 μg/mL, and then dispensed onto ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein arginine N-methyltransferase 5(Homo sapiens (Human))
Sk Biopharmaceuticals

US Patent
LigandPNGBDBM517940(8-[(3R)-1-acetylpyrrolidin-3-yl]oxy-4-[(2R)-3-(3,4...)
Affinity DataIC50:  50nMAssay Description:Experimental procedure: The histone H4 peptide was diluted with carbonate-bicarbonate buffer and prepared to 100 μg/mL, and then dispensed onto ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein arginine N-methyltransferase 5(Homo sapiens (Human))
Sk Biopharmaceuticals

US Patent
LigandPNGBDBM517944(8-[1-(cyclopropanecarbonyl)azetidin-3-yl]oxy-4-[(2...)
Affinity DataIC50:  50nMAssay Description:Experimental procedure: The histone H4 peptide was diluted with carbonate-bicarbonate buffer and prepared to 100 μg/mL, and then dispensed onto ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein arginine N-methyltransferase 5(Homo sapiens (Human))
Sk Biopharmaceuticals

US Patent
LigandPNGBDBM517946(4-[(2R)-3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydr...)
Affinity DataIC50:  50nMAssay Description:Experimental procedure: The histone H4 peptide was diluted with carbonate-bicarbonate buffer and prepared to 100 μg/mL, and then dispensed onto ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 256 total ) | Next | Last >>
Jump to: